MDWD
Mediwound Ltd
NASDAQ: MDWD · HEALTHCARE · BIOTECHNOLOGY
$16.25
-1.87% today
Updated 2026-04-29
Market cap
$208.85M
P/E ratio
—
P/S ratio
12.31x
EPS (TTM)
$-2.10
Dividend yield
—
52W range
$15 – $23
Volume
0.1M
Mediwound Ltd (MDWD) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $259000.00 | $601000.00 | $1.56M | $2.50M | $3.40M | $31.79M | $21.76M | $23.76M | $26.50M | $18.69M | $20.22M | $16.96M |
| Revenue growth (YoY) | — | — | — | — | +132.0% | +159.2% | +60.2% | +36.3% | +834.7% | -31.5% | +9.2% | +11.5% | -29.5% | +8.2% | -16.1% |
| Cost of revenue | — | $268000.00 | $335000.00 | $2.83M | $2.60M | $2.27M | $1.69M | $2.19M | $12.49M | $14.75M | $15.63M | $14.18M | $15.74M | $18.44M | $14.82M |
| Gross profit | — | $-268000.00 | $-335000.00 | $-2.58M | $-2.00M | $-712000.00 | $808000.00 | $1.21M | $19.30M | $7.01M | $8.14M | $12.32M | $2.95M | $1.78M | $2.13M |
| Gross margin | — | — | — | -994.2% | -333.4% | -45.7% | 32.4% | 35.6% | 60.7% | 32.2% | 34.2% | 46.5% | 15.8% | 8.8% | 12.6% |
| R&D | $3.02M | $1.32M | $3.36M | $5.35M | $6.02M | $7.04M | $5.42M | $4.02M | $4.63M | $7.35M | $9.90M | $9.61M | $7.07M | $8.25M | $13.49M |
| SG&A | $1.24M | $1.14M | $1.69M | $4.72M | $3.94M | $4.02M | $3.73M | $3.76M | $5.00M | $7.05M | $7.75M | $8.33M | $8.57M | $9.71M | $13.93M |
| Operating income | $-4.29M | $-2.73M | $-7.58M | $-21.43M | $-21.23M | $-20.16M | $-13.69M | $-10.75M | $5.67M | $-8.84M | $-11.22M | $-7.66M | $-15.50M | $-19.38M | $-25.28M |
| Operating margin | — | — | — | -8273.0% | -3531.9% | -1293.6% | -548.4% | -316.0% | 17.8% | -40.6% | -47.2% | -28.9% | -83.0% | -95.9% | -149.1% |
| EBITDA | $-4.10M | $12.25M | $-6.50M | $-18.33M | $-21.17M | $-18.30M | $-13.97M | $-5.09M | $3.42M | $-7.99M | $-12.12M | $-18.09M | $-4.89M | $-28.12M | $-23.57M |
| EBITDA margin | — | — | — | -7075.7% | -3522.1% | -1174.3% | -559.5% | -149.6% | 10.8% | -36.7% | -51.0% | -68.3% | -26.2% | -139.1% | -139.0% |
| EBIT | $-4.29M | $11.99M | $-6.83M | $-18.82M | $-21.67M | $-18.89M | $-14.53M | $-5.67M | $2.27M | $-9.08M | $-13.36M | $-19.36M | $-6.20M | $-29.60M | $-25.28M |
| Interest expense | $591000.00 | $673000.00 | $1.67M | $57000.00 | $444000.00 | $847000.00 | $827000.00 | $892000.00 | $207000.00 | $200000.00 | $167000.00 | $162000.00 | $335000.00 | $561000.00 | $662999.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-6.17M | $10.94M | $-15.35M | $-18.88M | $-22.09M | $-18.89M | $-22.15M | $-1.06M | $4.96M | $-9.20M | $-13.55M | $-19.60M | $-6.72M | $-30.22M | $-23.88M |
| Net income growth (YoY) | — | +277.3% | -240.3% | -23.0% | -17.0% | +14.5% | -17.3% | +95.2% | +568.8% | -285.6% | -47.4% | -44.6% | +65.7% | -350.0% | +21.0% |
| Profit margin | — | — | — | -7287.6% | -3675.2% | -1212.1% | -887.4% | -31.1% | 15.6% | -42.3% | -57.0% | -74.0% | -35.9% | -149.5% | -140.8% |